证券代码:000788 证券简称:北大医药 公告编号:2025-066 北大医药股份有限公司 关于持股5%以上股东减持股份的预披露公告

Group 1 - The core point of the announcement is that Beida Medical Management Co., Ltd. plans to reduce its holdings in Beida Pharmaceutical Co., Ltd. by up to 17,879,622 shares, which represents 3% of the total share capital of the company [1][2][3] - The reduction will occur through centralized bidding and block trading methods, with a maximum of 5,959,873 shares (1%) through centralized bidding and 11,919,749 shares (2%) through block trading [3][4] - The reduction period is set from October 14, 2025, to January 11, 2026, which is three months after the announcement [3][4] Group 2 - The reason for the reduction is stated as a need for personal funds [2] - The shares to be reduced were originally acquired during the restructuring of Founder Group, with Beida Medical Management Co., Ltd. inheriting 70,328,949 shares (11.80% of total shares) [2][3] - The company confirms that the reduction plan does not violate any existing commitments or regulations regarding shareholding reductions [5][6]